Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x

被引:53
作者
Lamhamedi-Cherradi, SE
Luan, JJ
Eloy, L
Fluteau, G
Bach, JF
Garchon, HJ
机构
[1] Hop Necker Enfants Malad, INSERM, U25, F-75743 Paris 15, France
[2] Hop Necker Enfants Malad, Inst Necker, F-75743 Paris, France
关键词
apoptosis; ontogeny; T lymphocyte; autoimmunity; diabetes mellitus;
D O I
10.1007/s001250050887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activated lymphocytes of autoimmune non-obese diabetic (NOD) mice exhibit an increased resistance to programmed cell death (PCD) following withdrawal of interleukin-2 (IL-2), In the present study, we found that resistance of NOD T lymphocytes to PCD was increased as early as 1 week of age, hence several weeks before the invasion of the pancreas by inflammatory cells, which is compatible with a role of the NOD apoptotic phenotype in the autoimmune susceptibility of this strain. In the thymus, mature single positive but not double positive or double negative thymocytes were more resistant to PCD in NOD compared lit BG mice. Moreover, in both NOD and BS mice, CD4+ T cells were more resistant to PCD induced by IL-2 deprivation than CD8+ cells. As a result, NOD CD4+ T cells were remarkably resistant to cell death induced in this manner, In relation with this increased resistance to apoptosis, expression of the anti-apoptotic Bcl-x protein was upregulated in activated T cells of NOD mice, most notably after 24 h of IL-2 deprivation, These results should help us to understand the relationship of the NOD apoptotic phenotype to the emergence of the NOD mouse autoimmune disease.
引用
收藏
页码:178 / 184
页数:7
相关论文
共 44 条
[1]   Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-x(L)) but not pro-apoptotic (bax, bcl-x(S)) gene expression [J].
Akbar, AN ;
Borthwick, NJ ;
Wickremasinghe, RG ;
Panayiotidis, P ;
Pilling, D ;
Bofill, M ;
Krajewski, S ;
Reed, JC ;
Salmon, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) :294-299
[2]   Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage [J].
Amrani, A ;
JafarianTehrani, M ;
Mormede, P ;
Durant, S ;
Pleau, JM ;
Haour, F ;
Dardenne, M ;
HomoDelarche, F .
JOURNAL OF ENDOCRINOLOGY, 1996, 148 (01) :139-148
[3]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[4]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[5]  
BROOME HE, 1995, J IMMUNOL, V155, P2311
[6]   THE MEIOSIS-SPECIFIC XMR GENE-PRODUCT IS HOMOLOGOUS TO THE LYMPHOCYTE XLR PROTEIN AND IS A COMPONENT OF THE XY BODY [J].
CALENDA, A ;
ALLENET, B ;
ESCALIER, D ;
BACH, JF ;
GARCHON, HJ .
EMBO JOURNAL, 1994, 13 (01) :100-109
[7]  
CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243
[8]   EXPRESSION OF INTERLEUKIN-2 RECEPTORS AS A DIFFERENTIATION MARKER ON INTRATHYMIC STEM-CELLS [J].
CEREDIG, R ;
LOWENTHAL, JW ;
NABHOLZ, M ;
MACDONALD, HR .
NATURE, 1985, 314 (6006) :98-100
[9]   BCL-X(L) AND BCL-2 REPRESS A COMMON PATHWAY OF CELL-DEATH [J].
CHAO, DT ;
LINETTE, GP ;
BOISE, LH ;
WHITE, LS ;
THOMPSON, CB ;
KORSMEYER, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :821-828
[10]   The role of Fas in autoimmune diabetes [J].
Chervonsky, AV ;
Wang, Y ;
Wong, FS ;
Visintin, I ;
Flavell, RA ;
Janeway, CA ;
Matis, LA .
CELL, 1997, 89 (01) :17-24